- EPCnews – European Perfumery and Cosmetics NEWS - https://www.epcnews.eu -

L’Oréal: First quarter 2011 sales – Good start to the year

[1]
loreal

Sales: 5.16 billion euros
+9.3% based on reported figures
+5.8% like-for-like
Strong growth in Consumer Products and Luxury ProductsGood performance in North AmericaContinuing dynamism in New Markets

Commenting on the figures, Mr Jean-Paul Agon, Chairman and CEO of L’Oréal, said:

“The start to this year is encouraging, as it confirms the group’s good dynamics, to which all divisions are contributing, particularly Consumer Products and Luxury Products, driven by the vitality of their major brands: L’Oréal Paris and Maybelline on the one hand, and Lancôme, Giorgio Armani and Kiehl’s, on the other.

In geographic terms, North America is accelerating strongly. Growth continues to be robust in the New Markets, particularly in Latin America, in Asia excluding Japan, and in Africa, Middle East. However, the situation remains more contrasting across Europe.

These performances reflect the quality of our innovations, the force and diversity of the brand portfolio, and the right balance in our geographic positions.

Although it is not possible to extrapolate from these figures, and despite an uncertain exchange rate environment, the first months of the year give us confidence in our ability to outperform the market in 2011, strengthen our worldwide positions, and achieve another year of growth in both sales and profits.”

A – First quarter 2011 sales

Like-for-like, i.e. based on a comparable structure and identical exchange rates, the sales growth of the L’Oréal group was +5.8%.
The net impact of changes in consolidation was +0.6%.
Currency fluctuations had a positive impact of +2.9%.
Growth at constant exchange rates was +6.4%.
Based on reported figures, the group’s sales at March 31, 2011 amounted to 5.16 billion euros, an increase of +9.3%.

Sales by operational division and geographic zone

Quarterly sales Growth
€m 1st quarter 2010 1st quarter 2011 Like-for-like Reported
By division
Professional Products 653 716 3.1% 9.6%
Consumer Products 2 363 2 584 6.3% 9.4%
Luxury Products 1 013 1 117 7.7% 10.3%
Active Cosmetics 417 445 4.9% 6.7%
Total cosmétique 4 445 4 861 6.0% 9.4%
By geographic zone
Western Europe 1 883 1 910 0.5% 1.5%
North America 998 1 117 7.2% 11.9%
New Markets, of which: 1 565 1 833 11.6% 17.2%
–   Asia, Pacific 772 917 11.7% 18.8%
–   Eastern Europe 352 355 -1.5% 0.7%
–   Latin America 307 404 24.1% 31.5%
–   Africa, Middle East 134 158 16.0% 18.4%
Cosmetics total 4 445 4 861 6.0% 9.4%
The Body Shop 164 170 0.8% 3.2%
Dermatology(1) 112 130 5.9% 15.5%
Group total 4 722 5 160 5.8% 9.3%

(1) Group share, i.e. 50%.

1) Cosmetics sales

PROFESSIONAL PRODUCTS

In the first quarter the Professional Products Division posted growth of +3.1% like-for-like, faster than the market trend, and +9.6% based on reported figures (after taking into account the impact of currency fluctuations and of changes in consolidation due to the acquisition of distributors in the United States). It continued its expansion with an additional 20,000 active salons compared to the first quarter of 2010.

CONSUMER PRODUCTS

The Consumer Products Division achieved sales growth of +6.3% like-for-like, and +9.4% based on reported figures. The division is continuing to strongly advance in North America and in the New Markets.

LUXURY PRODUCTS

The Luxury Products Division recorded growth of +7.7% like-for-like and +10.3% based on reported figures. The division’s sell-out accelerated significantly in the United States, and remained very dynamic in the New Markets.

ACTIVE COSMETICS

The sales of the Active Cosmetics Division at end-March grew by +4.9% like-for-like and +6.7% based on reported figures, thanks to the dynamism of the New Markets, particularly Latin America.

Multi-division summary by geographic zone

WESTERN EUROPE

In a globally flat market, the group achieved growth of +0.5% like-for-like, and +1.5% based on reported figures, thanks in particular to the United Kingdom, Northern Europe, and continuing dynamism in Travel Retail. The situation is more uncertain in some South European countries.

NORTH AMERICA

In the first quarter, North America achieved growth of +7.2% like-for-like and +11.9% based on reported figures. All divisions recorded positive growth. The Luxury Products Division made a good start to the year, with in particular a rebound at Lancôme, while the Consumer Products Division is making clear market share gains in all categories.

NEW MARKETS

With growth of +11.6% like-for-like and +17.2% based on reported figures, the group is continuing to strengthen its positions. Excluding Japan, the New Markets zone is at +13.0% like-for-like.

2) The Body Shop sales

At end-March, The Body Shop sales recorded like-for-like growth at +0.8%. Retail sales(1) are at +0.9%.
The Body Shop is recording very strong growth rates in the New Markets, particularly in the Middle East, Eastern Europe and Southern Asia, and is continuing to extend its distribution in these areas. The brand is also making great strides forward in e-commerce and in Travel Retail, where its visibility is increasing. On the other hand, the brand is feeling the impact of an environment seriously affected by natural disasters in Japan and Australia.The Body Shop is stepping up its militant approach to innovations, with launches including Earthlovers, a range of eco-designed, 100%-biodegradable shower gels.
At end-March 2011, The Body Shop has a total of 2,613 stores.

(1) Retail sales: total sales to consumers through all channels, including franchisees.

3) Galderma sales

Galderma’s sales increased by +5.9%, like-for-like.

Epiduo (acne), Azzalure (muscle relaxant for frown lines) and Cetaphil (therapeutic skincare) recorded double digit growth and compensated sales erosion due to the entry of generics of Differin 0.1% gel and cream (acne) in the United States, and Loceryl nail lacquer (onychomycosis) in France. Southeast Asia and South Korea in particular show solid growth, as do Canada, Brazil and Argentina.There was a slowdown in sales in Galderma’s traditional markets in Europe and the United States.

The main event of the last quarter was the completion on February 25, 2011 of the cash offer for the acquisition of Q-Med launched on January 3, 2011. Q-Med is the leader in developing and commercialising medical device products based on hyaluronic acid which includes the facial dermal filler Restylane and Macrolane for body contouring. The expanded portfolio accelerates Galderma’s strategy for growing its aesthetic procedures business, catapulting the company into a leading position in the global market for injectables and allowing the company to more effectively meet the needs of doctors and patients. Q-Med has been consolidated in Galderma’s financial statements since March 1, 2011.

[Text/Logo: L’Oréal]